Biopharma | May 18, 2026
Kotak Alts invests Rs. 200 million in Cellogen Therapeutics
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
Offers a non-surgical treatment option for tricuspid regurgitation, a commonly underdiagnosed heart valve disorder linked to heart failure
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Subscribe To Our Newsletter & Stay Updated
